Intuitive Q3 sales rise as $450 million charge weighs on GAAP profit
Intuitive Surgical (ISRG) reported third-quarter revenue of $3.05 billion, up 22% from a year earlier, on October 20. GAAP diluted earnings fell to $1.49 per share from $1.95, with results including a $450 million pre-tax antitrust settlement charge.[1]
The earnings distinction
The settlement expense was $347 million after tax, or $0.99 per diluted share. Non-GAAP diluted earnings were $3.00 per share, compared with $2.40 in the third quarter of 2025.[1]
Intuitive reached the settlement agreement without admitting liability or wrongdoing. It remains subject to preliminary and final court approval.[1]
Why it matters for shareholders
Analysis.The sales growth and lower GAAP profit tell different parts of the quarter’s story. Shareholders assessing operating momentum need to keep the reported results, adjusted figures and litigation expense distinct. Court approval remains a separate uncertainty from the charge already recorded.[1]
Sources
- 1.Intuitive October 20 Q3 release, SEC exhibitOct 20, 2026
Prepared with AI assistance. Reviewed by AlphaYou automated editorial review. Report a correction.